Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Journal of the American Academy of Dermatology
|
April 26, 2026
Comparative Two-Year Drug Survival of Bimekizumab and Brodalumab in Second-Line Treatment of Psoriasis
Christopher Willy Schwarz, Nikolai Loft, Lars Erik Bryld, et al.
JAMA Dermatology
|
January 7, 2026
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
Christopher Willy Schwarz, Nikolai Loft, Lars Erik Bryld, et al.
Journal of the American Academy of Dermatology
|
February 5, 2023
Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Mia-Louise Nielsen, David Thein, Mads Kirchheiner Rasmussen, et al.
JAMA Dermatology
|
August 17, 2022
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level
Mia-Louise Nielsen, Troels Christian Petersen, Julia-Tatjana Maul, et al.
Ugeskrift for Laeger
|
April 2, 2025
[Hidradenitis suppurativa]
Hans Christian Ring, Peter Theut Riis, Mads Rasmussen, et al.
Acta Dermato-Venereologica
|
March 3, 2025
Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study
Johan Sieborg, Julia-Tatjana Maul, Jashin J Wu, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory
Thomas Emmanuel, Borislav Ignatov, Trine Bertelsen, et al.
Ugeskrift for Laeger
|
November 21, 2025
[Vaccination of individuals undergoing immunosuppressive therapy]
Zitta Barrella Harboe, Peter Henrik Andersen, Peter Asdahl, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Journal of the American Academy of Dermatology
|
April 26, 2026
Comparative Two-Year Drug Survival of Bimekizumab and Brodalumab in Second-Line Treatment of Psoriasis
Christopher Willy Schwarz, Nikolai Loft, Lars Erik Bryld, et al.
JAMA Dermatology
|
January 7, 2026
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
Christopher Willy Schwarz, Nikolai Loft, Lars Erik Bryld, et al.
Journal of the American Academy of Dermatology
|
February 5, 2023
Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Mia-Louise Nielsen, David Thein, Mads Kirchheiner Rasmussen, et al.
JAMA Dermatology
|
August 17, 2022
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level
Mia-Louise Nielsen, Troels Christian Petersen, Julia-Tatjana Maul, et al.
Ugeskrift for Laeger
|
April 2, 2025
[Hidradenitis suppurativa]
Hans Christian Ring, Peter Theut Riis, Mads Rasmussen, et al.
Acta Dermato-Venereologica
|
March 3, 2025
Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study
Johan Sieborg, Julia-Tatjana Maul, Jashin J Wu, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory
Thomas Emmanuel, Borislav Ignatov, Trine Bertelsen, et al.
Ugeskrift for Laeger
|
November 21, 2025
[Vaccination of individuals undergoing immunosuppressive therapy]
Zitta Barrella Harboe, Peter Henrik Andersen, Peter Asdahl, et al.
Page
of 4